postgenomic era, researchers will access, model, analyze, and mine vast volumes and multiple types of data on various scales. New computer-based approaches or algorithmic-based approaches must tackle these challenges, in the areas of functional genomics, comparative genomics, proteomics, metabolomics, pathway analysis, and systems biology.
TECHNIQUES AT THE MICRO/NANO LEVELS

HIGH-THROUGHPUT CELL IMAGING
As the pharmaceutical industry is faced with an escalation in the amount of time and money required for drug discovery and development, there is a growing need to increase confidence in early stage targets, improve lead selection, and reduce late-stage attribution. An equally important issue is how to choose the best therapeutics from an increasingly large drug arsenal for patients with various conditions. In addition t o microarray technologies [2] - [6] , another promising technology for improving such decision-making is cellular imaging-based assays. This technology allows the functional analysis of target and pathway modulation in cells. Highthroughput screening methods, such as transcriptional and proteomic profiling, are discussed in [7] and [8] . There are many types of high-throughput cellular data, capturing DNA polymorphism, gene activation, mRNAs, proteins, metabolites, calcium flux, cytotoxicity,
[FIG1] Multiscale biomedical systems, ranging from macroscale patients and organs to microscopic cells and nanoscale genetic data.
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Proteomics
Massive parallel operations can identify and characterize changes in the overall protein and yield important insights into effects of disease and drug reactions.
Genomics
Parallel operations to produce sequence strings and annotations that identify the regions of the human genome (genes, clones, etc.), maps of the human genome, and variations within the human genome. To harness the power of this new high-throughput spatial and temporal information, we need to increase data acquisition throughput and to process and quantitate large amounts of image data effectively. By using automated microscopy (shown in Figure 2 ), combined with imaging techniques that show protein locations, cell structures, and physiological states of cells, researchers can increasingly observe system biology events such as multiple cellular events and intracellular events in individual cells [9] , [10] . Quantitative cytological information available at early stages in the drug discovery process improves our understanding of drug targets and compound leads. However, the image informatics tools that are required to automate, quantitate, and analyze cellular information on such a large scale have not yet been developed to complement the highthroughput imaging technologies that have already been adopted. The availability of the informatics tools would enable the close coupling of automated microscopy and image analysis with biostatistical and data mining techniques to provide an integrated system biologic approach to studying cells, the basic units of life. These informatics tools would also have many exciting applications in the life and health sciences.
Genes
Compounds that affect spatial arrangement of signaling proteins or cellular structures can provide important information about biological processes and therapeutic interventions. To identify such compounds using a u t o m a t e d fluorescence microscopy is part of the "forward chemical genetics" approach [11] , [12] . Effort is being directed towards highthroughput, image-based screening of large chemical libraries. Currently, about a dozen commercial vendors offer automated fluorescence imagers. Most, however, are assembled using off-theshelf components. Their prices range from hundreds of thousands to over US$1 million for the high-end products.
More than 20 cellular imaging assays have been developed and screened via our in-house compound libraries, consisting of approximately 100,000 commercial and 100,000 diversity-oriented synthesis (DOS) compounds (refer to Table 1 ). Please also refer to http://iccb. med.harvard.edu/screening/compound_libraries/index.htm for details on the compound library.
The major advantage offered by imaging is that it allows us to score changes in individual cells within a population of hundreds or thousands of cells, rather than simply finding cell population averages, as traditional means allow. This potentially enhances our ability to identify cell changes. 
NANOTECHNOLOGY
DISCUSSIONS
Here we discuss a number of open research issues.
HIGH-THROUGHPUT CELL IMAGING
We began our work by measuring changes in three cellular markers: DNA, splicesome, and cell-cycle-regulated protein anillin. They were compared to a panel of 60 known bioactive compounds in serial dilution (see Figure 3) . HeLa cells grown in 384 well plates were treated with a certain compound in a concentration ranging from 0.1 pM to 200 µM for 20 hours. The cells were then fixed and stained with antibodies to show the above three biomarkers simultaneously using different fluorescent dyes. The image data were then recorded using an autoscope equipped with a 20× lens and DAPI/FITC/TxRed filter set. Nine data points were recorded for each condition, and approximately 300 GB of image data were collected.
One application of high-throughput cellular imaging for system biology is cytological profiling. Profiling studies typically have two outputs, namely, identifying similarities at the global level and generating mechanistic hypotheses using particular subsets of measurements. Our cytological data, which measures the response of cell pathways to drugs (compounds), can be mined for hypotheses concerning cell responses at the system level. We believe that cytological profiling using this type of image informatics approach is a fast and effective method of gathering broad, quantitative phenotypic information from individual cultured cells. We can use it to categorize drug mechanisms, and similar methods should be useful for annotating RNAi screens and profiling cancer phenotypes. Cytological profiling provides information complementary to existing high-throughput profiling techniques, such as transcript and proteomic profiling. It also has the advantage of requiring far fewer cells per data point, and it is faster and cheaper when a limited number of fluorescent probes are employed.
NANOTECHNOLOGY
We proposed the use of relatively inert carbon nanotube structures to induce a cytotoxic radical activity cascade for cancer treatment. The research is carried out in the following steps:
■ By analyzing the quantum states of nanotubes under certain magnetic or electrical field conditions, we can determine the possibility that electrons in carbon nanotubes can transfer energy. These conditions can also excite the ground state radical (triplet) O 2 into its nonradical excited single state. We are also investigating the effect of phonon energy transfer into other biologically available compounds that exhibit cytotoxic effects. ■ We are exploring means to excite nanotubes remotely to induce a cytotoxic cascade. This would allow the activation of our cytotoxic agent (nanotubes) even in the deepest or most inaccessible tumor sites. ■ We are also developing a method to deliver our cytotoxic nanotubes to specific tumor sites. This will be absolutely necessary as there will be no way to form highly localized magnetic fields within an organism. In the presence of our activating magnetic field, all of our nanotubes will become cytotoxic; thus, we need to ensure that they are localized to the tumor site.
In this article, we have briefly reviewed two emerging technologies for studying biomedical systems on the micro and nano scales. High-throughput imaging technologies have fundamentally changed the way in which we perform 
